GNS Healthcare Nets $10M in Series B Financing | GenomeWeb

NEW YORK (GenomeWeb News) — GNS Healthcare has reeled in $10 million in financing that it will use to expand its data analytic business more broadly across the healthcare industry.

The series B financing included participation from previous investor Cambia Health Solutions and from California's Heritage Provider Network and Mitsui and Co., Cambridge, Mass.-based GNS Healthcare said yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.